0001213900-23-067069 | 10-Q | XBRL Viewer

Organization, Description of Business and Liquidity (Details) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Mar. 28, 2022	Mar. 09, 2022
Organization, Description of Business and Liquidity (Details) [Line Items]
Shares issued									250,000,000
Outstanding membership interests								51,250,000
Accumulated deficit (in Dollars)	$ (3,019,426)				$ (3,019,426)		$ (627,118)
Net loss (in Dollars)	$ (1,321,057)	$ (1,071,251)	$ (245,139)	$ (84,200)	(2,392,308)	$ (329,339)
Net proceeds (in Dollars)					$ 6,600,000
Preferred Stock [Member]
Organization, Description of Business and Liquidity (Details) [Line Items]
Shares issued									50,000,000
Common Stock, par value per share (in Dollars per share)									$ 0.0001
Net loss (in Dollars)
Class A Common Stock [Member]
Organization, Description of Business and Liquidity (Details) [Line Items]
Shares issued								9,756,000	10,000,000
Common Stock, par value per share (in Dollars per share)									$ 0.0001
Class B Common Stock [Member]
Organization, Description of Business and Liquidity (Details) [Line Items]
Shares issued	5,375,724				5,375,724		2,364,724	244,000	190,000,000
Common Stock, par value per share (in Dollars per share)									$ 0.0001

Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
Statements of Cash Flows (Unaudited) - USD ($)	Jun. 30, 2023	Jun. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (2,392,308)	$ (329,339)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock based compensation	603,925
Changes in operating assets and liabilities:
Accounts receivable		(1,300)
Prepaid expenses	(71,096)
Accounts payable and accrued expenses	(126,792)	32,634
Contract liabilities	20,226	4,303
Net cash used in operating activities	(1,966,045)	(293,702)
CASH FLOWS FROM FINANCING ACTIVITIES
Class B common stock subscription proceeds received, net	6,845,050	399,925
Deferred offering costs		(24,530)
Net cash provided by financing activities	6,845,050	375,395
Net change in cash	4,879,005	81,693
Cash at beginning of period	137,177	33,731
Cash at end of period	5,016,182	115,424
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for income taxes
Cash paid for interest
NON CASH INVESTING AND FINANCING ACTIVITIES
Conversion from Class A to Class B common stock		$ 77

Stockholders' Equity (Details) - USD ($)			1 Months Ended	6 Months Ended	12 Months Ended
Stockholders' Equity (Details) - USD ($)	Feb. 07, 2023	Feb. 03, 2023	Mar. 28, 2022	Jun. 30, 2023	Dec. 31, 2022	Mar. 09, 2022
Stockholders' Equity (Details) [Line Items]
Common stock, shares issued						250,000,000
Preferred stock, shares authorized				50,000,000	50,000,000
Preferred stock, par value (in Dollars per share)				$ 0.0001	$ 0.0001
Stock units			51,250,000
Warrants issued	105,000			8,385,276	8,385,276
Underwriting discounts and commissions (in Dollars)		$ 884,880
Other expenses (in Dollars)		6,615,120
Granted shares				1,511,000
Directors and executive officers (in Dollars)				$ 3,532,130
Common stock shares outstanding				5,375,724
Shares vested				118,000
Purchase shares	105,000
Aggregate shares percentage	7.00%
Exercise price (in Dollars per share)	$ 6.25
Public offering price percentage	125.00%
Intrinsic value (in Dollars)				$ 0
Preferred Stock [Member]
Stockholders' Equity (Details) [Line Items]
Common stock, shares issued						50,000,000
Preferred stock, shares authorized						50,000,000
Preferred stock, par value (in Dollars per share)						$ 0.0001
Class A Common Stock [Member]
Stockholders' Equity (Details) [Line Items]
Common stock, shares authorized						250,000,000
Common stock, shares issued			9,756,000			10,000,000
Common stock, par value (in Dollars per share)						$ 0.0001
Common stock shares outstanding				8,385,276	8,385,276
Stock-based compensation expense (in Dollars)				$ 603,925
Class B Common Stock [Member]
Stockholders' Equity (Details) [Line Items]
Common stock, shares authorized						190,000,000
Common stock, shares issued			244,000	5,375,724	2,364,724	190,000,000
Common stock, par value (in Dollars per share)						$ 0.0001
Gross proceeds (in Dollars)		$ 7,500,000
Granted shares					2,750,000
Common stock shares outstanding				5,275,724	2,364,724

Stockholders' Equity

6 Months Ended

Jun. 30, 2023

Stockholders' Equity [Abstract]

Stockholders' Equity

Note 3. Stockholders’ Equity

Authorized Capital Stock

On March 9, 2022, the Company filed Articles of Incorporation with the state of Nevada to authorize the Company to issue 250,000,000 shares, consisting of 10,000,000 shares of Class A Common Stock, $0.0001 par value per share (“Class A Common”), 190,000,000 shares of Class B Common stock, $0.0001 par value per share (“Class B Common”), and 50,000,000 shares of Preferred Stock, $0.0001 par value (the “Preferred Stock”).

On March 28, 2022, all 51,250,000 units of the previously outstanding membership interests were exchanged for 9,756,000 shares of Class A Common Stock and 244,000 shares of Class B Common Stock.

Preferred Stock

The Company shall have the authority to issue the shares of Preferred Stock in one or more series with such rights, preferences and designations as determined by the Board of Directors of the Company.

Class A Common Stock

Each share of Class A Common Stock entitles the holder to ten (10) votes, in person or proxy, on any matter on which an action of the stockholders of the Company is sought and is convertible by the holder into one (1) share of Class B Common Stock.

The Company had 8,385,276 shares of Class A Common Stock issued and outstanding as of June 30, 2023 and December 31, 2022.

Class B Common Stock

Each share of Class B Common Stock entitles the holder to one (1) vote, in person or proxy, on any matter on which an action of the stockholders of the Company is sought.

On February 3, 2023, the Company closed an initial public offering of its class B common stock. The Company raised total gross proceeds of $7,500,000 in the offering, and after deducting $884,880 of underwriting discounts and commissions, the non-accountable expense allowance, and other expenses from the offering, the Company received net proceeds of $6,615,120.

During the six months ended June 30, 2023, the Company granted 1,511,000 shares of class B restricted stock awards (“RSA”) under the 2022 Equity Incentive Plan (“2022 Plan”) to directors and executive officers, valued at $3,532,130.

The Company had 5,375,724 and 2,364,724 shares of Class B Common Stock issued and outstanding as of June 30, 2023 and December 31, 2022, respectively.

2022 Equity Incentive Plan

The maximum number of shares of Class B Common Stock that may be issued pursuant to awards granted under the 2022 Plan is 2,750,000 shares. Awards that may be granted include: (a) Incentive Stock Options, or ISO (b) Non-statutory Stock Options, (c) Stock Appreciation Rights, (d) Restricted Stock, (e) Restricted Stock Units, or RSUs, (f) Stock granted as a bonus or in lieu of another award, and (g) Performance Awards. These awards offer us and our shareholders the possibility of future value, depending on the long-term price appreciation of our Class B Common Stock and the award holder’s continuing service with us.

The RSA shares to directors vest quarterly for one year from the date of grantee’s appointment as a director. The RSA shares to officers vest annually over three years from the grant date. RSA shares are measured at fair market value on the date of grant and stock-based compensation expense is recognized as the shares vest with a corresponding offset credited to additional paid-in-capital. For the six months ended June 30, 2023, the Company recorded stock-based compensation expense of $603,925. As of June 30, 2023, 118,000 RSA shares have vested.

Warrants

On February 7, 2023, the Company issued 105,000 warrants exercisable into 105,000 shares of the Company’s Class B Common Stock which is equal to 7% of the aggregate number of shares of Class B Common Stock sold in the above mentioned initial public offering. These warrants carry an exercise price of $6.25 per share, which is equal to 125% of the public offering price, subject to adjustment, the warrants also include a cashless exercise provision; these warrants may be exercised at any time for five years following the date of issuance.

A summary of activity for six months ended June 30, 2023, follows:

			Weighted		Weighted
	Number of		Average		Average
	shares		Exercise Price		Life (years)
Outstanding, December 31, 2022		52,500	$	6.25		4.68
Granted		105,000		6.25
Expired		-		-		-
Exercised		-		-		-
Outstanding, June 30, 2023		157,500	$	6.25		4.47

All of the outstanding warrants are exercisable as of June 30, 2023. The intrinsic value of the warrants as of June 30, 2023, is $0.

- Definition

The entire disclosure for equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-14

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481004/946-505-50-6

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480237/815-40-50-6

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//505/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-14

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-14

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 16
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-16

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-18

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-18

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-18

+ Details

Statement of Stockholders' Equity (Unaudited) - USD ($)	Class A Common stock	Class B Common stock	Additional Paid in Capital	Retained earnings (Accumulated Deficit)	Subscription Receivable	Total
Balance at Dec. 31, 2021	$ 976	$ 24	$ 249,976	$ 18,137	$ (225,976)	$ 43,137
Balance (in Shares) at Dec. 31, 2021	9,756,000	244,000
Subscription received					75,000	75,000
Net loss				(84,200)		(84,200)
Balance at Mar. 31, 2022	$ 976	$ 24	249,976	(66,063)	(150,976)	33,937
Balance (in Shares) at Mar. 31, 2022	9,756,000	244,000
Balance at Dec. 31, 2021	$ 976	$ 24	249,976	18,137	(225,976)	43,137
Balance (in Shares) at Dec. 31, 2021	9,756,000	244,000
Net loss						(329,339)
Balance at Jun. 30, 2022	$ 899	$ 126	424,876	(311,202)	(976)	113,723
Balance (in Shares) at Jun. 30, 2022	8,985,276	1,264,724
Balance at Mar. 31, 2022	$ 976	$ 24	249,976	(66,063)	(150,976)	33,937
Balance (in Shares) at Mar. 31, 2022	9,756,000	244,000
Conversion from Class A Common Stock to Class B Common Stock	$ (77)	$ 77
Conversion from Class A Common Stock to Class B Common Stock (in Shares)	(770,724)	770,724
Class B common stock and warrant issued		$ 25	174,900			174,925
Class B common stock and warrant issued (in Shares)		250,000
Subscription received					150,000	150,000
Net loss				(245,139)		(245,139)
Balance at Jun. 30, 2022	$ 899	$ 126	424,876	(311,202)	$ (976)	113,723
Balance (in Shares) at Jun. 30, 2022	8,985,276	1,264,724
Balance at Dec. 31, 2022	$ 839	$ 236	779,826	(627,118)		153,783
Balance (in Shares) at Dec. 31, 2022	8,385,276	2,364,724
Class B common stock and warrant issued		$ 150	6,540,343			6,540,493
Class B common stock and warrant issued (in Shares)		1,500,000
Class B Common stock issued for restricted stock awards		$ 141	200,069			200,210
Class B Common stock issued for restricted stock awards (in Shares)		1,411,000
Net loss				(1,071,251)		(1,071,251)
Balance at Mar. 31, 2023	$ 839	$ 527	7,520,238	(1,698,369)		5,823,235
Balance (in Shares) at Mar. 31, 2023	8,385,276	5,275,724
Balance at Dec. 31, 2022	$ 839	$ 236	779,826	(627,118)		153,783
Balance (in Shares) at Dec. 31, 2022	8,385,276	2,364,724
Net loss						(2,392,308)
Balance at Jun. 30, 2023	$ 839	$ 537	7,923,943	(3,019,426)		4,905,893
Balance (in Shares) at Jun. 30, 2023	8,385,276	5,375,724
Balance at Mar. 31, 2023	$ 839	$ 527	7,520,238	(1,698,369)		5,823,235
Balance (in Shares) at Mar. 31, 2023	8,385,276	5,275,724
Class B Common stock issued for restricted stock awards		$ 10	403,705			403,715
Class B Common stock issued for restricted stock awards (in Shares)		100,000
Net loss				(1,321,057)		(1,321,057)
Balance at Jun. 30, 2023	$ 839	$ 537	$ 7,923,943	$ (3,019,426)		$ 4,905,893
Balance (in Shares) at Jun. 30, 2023	8,385,276	5,375,724

Accounting Policies, by Policy (Policies)

6 Months Ended

Jun. 30, 2023

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The Company prepares its financial statements in accordance with rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and generally accepted accounting principles in the United States of America (“GAAP”). The accompanying interim financial statements have been prepared in accordance with GAAP for interim financial information in accordance with Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the Company’s opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 2023, are not necessarily indicative of the results for the full year. While management of the Company believes that the disclosures presented herein are adequate and not misleading, these interim financial statements should be read in conjunction with the audited financial statements and the footnotes thereto for the year ended December 31, 2022, contained in the Company’s Form 10-K filed on June 30, 2023.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates.

Cash and Cash Equivalents

Cash and Cash Equivalents

For purposes of balance sheet presentation and reporting of cash flows, the Company considers all unrestricted demand deposits, money market funds and highly liquid debt instruments with an original maturity of less than 90 days to be cash and cash equivalents. The Company had no cash equivalents at June 30, 2023 and December 31, 2022.

Periodically, the Company may carry cash balances at financial institutions more than the federally insured limit of $250,000 per institution. The amount in excess of the FDIC insurance as of June 30, 2023, was approximately $4.8 million. The Company has not experienced losses on account balances and management believes, based upon the quality of the financial institutions, that the credit risk with regard to these deposits is not significant.

Accounts Receivable

Accounts Receivable

Accounts receivable are recorded in accordance with ASC 310, “Receivables.” Accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts is the Company’s best estimate of the amount of probable credit losses in its existing accounts receivable. The Company had no accounts receivable of as of June 30, 2023 to account for the delinquency related to one specific transaction. Based on management’s estimate under the expected credit loss model and based on all other accounts being current and settled, the Company has not deemed it necessary to make any additional general provision for doubtful accounts at the time of this report. To measure expected credit losses, accounts receivable are grouped based on shared risk characteristics and days past due.

Deferred Offering Costs

Deferred Offering Costs

As of December 31, 2022, deferred offering costs represent legal fees for preparation of any securities purchase agreements or current registration statement. The Company records these fees as a current asset that will be netted against gross proceeds received from any offering or placements. In February 2023, the Company issued common stock as initial public offering and recorded offering cost as additional paid in capital.

Fair Value Measurements

Fair Value Measurements

The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows:

●

Level 1—Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets;

●

Level 2—Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and

●

Level 3—Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.

The Company’s financial instruments, including cash, accounts receivable, prepaid expense, deferred offering costs and contract liabilities, other current liabilities are carried at historical cost. At June 30, 2023 and December 31, 2022, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments.

Revenue Recognition

Revenue Recognition

The Company recognizes revenue utilizing the following steps: (i) Identify the contract, or contracts, with a customer; (ii) Identify the performance obligations in the contract; (iii) Determine the transaction price; (iv) Allocate the transaction price to the performance obligations in the contract; (v) Recognize revenue when the Company satisfies a performance obligation.

Subscriptions

Subscription revenue is related to a single performance obligation that is recognized over time when earned. Subscriptions are paid in advance and can be purchased on a monthly, quarterly, or annual basis. Any quarterly or annual subscription revenue is recognized as a contract liability expensed over the contracted service period.

Marketing

Revenue related to marketing campaign contracts with customers are normally of a short duration, typically less than two weeks.

AE.360.DDM Contracts

Revenue related to AE.360.DDM contracts with customers are normally of a short duration, typically less than one week.

Contract Liabilities

Contract Liabilities

Contract liabilities consist of quarterly and annual subscription revenue that have not been recognized. As of June 30, 2023 and December 31, 2022, total contract liabilities were $24,874 and $4,648, respectively. Contract liabilities are typically expected to be recognized to revenue over a period not to exceed twelve (12) months.

Earnings per Share of Common Stock

Earnings per Share of Common Stock

The Company has adopted ASC Topic 260, “Earnings per Share” which requires presentation of basic earnings per share on the face of the statements of operations for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic earnings per share computation. In the accompanying financial statements, basic loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per share is computed by dividing net income by the weighted average number of shares of common stock and potentially dilutive outstanding shares of common stock during the period to reflect the potential dilution that could occur from common stock issuable through contingent share arrangements, stock options and warrants unless the result would be antidilutive. The Company would account for the potential dilution from convertible securities using the as-if converted method. The Company accounts for warrants and options using the treasury stock method. As of June 30, 2023, dilutive potential common shares include outstanding warrants.

Income Taxes

Income Taxes

As described in more detail above, the business now conducted by the Company was operated as a partnership from August 1, 2020 until October 19, 2020, when it was reorganized as a limited liability company, or LLC, and that LLC was merged into the Company on March 28, 2022. Prior to that date, the partnership and the subsequent LLC were not subject to federal income tax and all income, deductions, gains and losses were attributed to the partners or members.

The Company adopted FASB ASC 740, Income Taxes, at its inception. Under FASB ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss and credit carryforwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred income tax expense represents the change during the period in the deferred tax assets and deferred tax liabilities. The components of the deferred tax assets and liabilities are individually classified as current and non-current based on their characteristics. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

Related Parties

Related Parties

The Company follows ASC 850, “Related Party Disclosures”, for the identification of related parties and disclosure of related party transactions and balances.

Commitments and Contingencies

Commitments and Contingencies

The Company follows ASC 450-20, “Loss Contingencies”, to report accounting for contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

In June 2022, the FASB issued ASU 2022-03, ASC Subtopic “Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions”. These amendments clarify that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The amendments in this update are effective for public business entities for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2023. Early adoption is permitted. The Company is currently assessing the impact of the adoption of this standard on its financial statements.

The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements.

Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
Statements of Operations (Unaudited) - USD ($)	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Revenues	$ 74,912	$ 72,664	$ 136,047	$ 198,723
Operating expenses
Contract labor	48,083	51,289	84,664	82,084
General and administrative	497,713	119,027	843,654	239,637
Management compensation	850,173	147,487	1,600,037	206,341
Total operating expenses	1,395,969	317,803	2,528,355	528,062
Loss from operations	(1,321,057)	(245,139)	(2,392,308)	(329,339)
Net loss	$ (1,321,057)	$ (245,139)	$ (2,392,308)	$ (329,339)
Loss per share of common stock - basic (in Dollars per share)	$ (0.1)	$ (0.02)	$ (0.18)	$ (0.03)
Weighted average number of shares of common stock outstanding - basic (in Shares)	13,712,648	10,060,440	13,091,901	10,030,220

Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Current Assets
Cash	$ 5,016,182	$ 137,177
Prepaid expenses	71,096
Deferred offering costs		235,844
Total Current Assets	5,087,278	373,021
TOTAL ASSETS	5,087,278	373,021
Current Liabilities
Accounts payable and credit card liability	156,511	214,590
Contract liabilities	24,874	4,648
Total Current Liabilities	181,385	219,238
TOTAL LIABILITIES	181,385	219,238
Commitments and contingencies
Stockholders’ Equity
Preferred Stock; $0.0001 par value, 50,000,000 authorized
Common Stock; $0.0001 par value, 200,000,000 authorized
Class A Common Stock; $0.0001 par value, 10,000,000 authorized 8,385,276 shares issued and outstanding	839	839
Class B Common Stock; $0.0001 par value, 190,000,000 authorized 5,375,724 and 2,364,724 shares issued and outstanding, respectively	537	236
Additional paid in capital	7,923,943	779,826
Subscription receivable
Accumulated deficit	(3,019,426)	(627,118)
Total Stockholders’ Equity	4,905,893	153,783
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 5,087,278	$ 373,021

Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2023

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2. Summary of Significant Accounting Policies

Basis of Presentation

Use of Estimates

Cash and Cash Equivalents

Accounts Receivable

Deferred Offering Costs

Fair Value Measurements

●

Level 1—Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets;

●

Level 2—Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and

●

Level 3—Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.

Revenue Recognition

Subscriptions

Marketing

Revenue related to marketing campaign contracts with customers are normally of a short duration, typically less than two weeks.

AE.360.DDM Contracts

Revenue related to AE.360.DDM contracts with customers are normally of a short duration, typically less than one week.

Contract Liabilities

Earnings per Share of Common Stock

Income Taxes

Related Parties

The Company follows ASC 850, “Related Party Disclosures”, for the identification of related parties and disclosure of related party transactions and balances.

Commitments and Contingencies

Recent Accounting Pronouncements

The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements.

Document And Entity Information - shares	6 Months Ended
Document And Entity Information - shares	Jun. 30, 2023	Aug. 14, 2023
Document Information Line Items
Entity Registrant Name	ASSET ENTITIES INC.
Trading Symbol	ASST
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Entity Central Index Key	0001920406
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Jun. 30, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	false
Entity Ex Transition Period	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-41612
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	88-1293236
Entity Address, Address Line One	100 Crescent Ct
Entity Address, Address Line Two	7th Floor
Entity Address, City or Town	Dallas
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75201
City Area Code	(214)
Local Phone Number	459-3117
Title of 12(b) Security	Class B Common Stock, $0.0001 par value per share
Security Exchange Name	NASDAQ
Entity Interactive Data Current	Yes
Class A Common Stock
Document Information Line Items
Entity Common Stock, Shares Outstanding		8,385,276
Class B Common Stock
Document Information Line Items
Entity Common Stock, Shares Outstanding		5,375,724

Stockholders' Equity (Details) - Schedule of Warrants as Equity-Classified Instruments	6 Months Ended
	Jun. 30, 2023 $ / shares shares
Schedule of Warrants as Equity Classified Instruments [Abstract]
Number of Shares, Outstanding Beginning \| shares	52,500
Weighted Average Exercise Price,Outstanding Beginning \| $ / shares	$ 6.25
Weighted Average Life (years), Outstanding Beginning	4 years 8 months 4 days
Number of Shares, Granted \| shares	105,000
Weighted Average Exercise Price, Granted \| $ / shares	$ 6.25
Number of Shares, Expired \| shares
Weighted Average Exercise Price, Expired \| $ / shares
Weighted Average Life (years), Expired
Number of Shares, Exercised \| shares
Weighted Average Exercise Price, Exercised \| $ / shares
Weighted Average Life (years), Exercised
Number of Shares, Outstanding Ending \| shares	157,500
Weighted Average Exercise Price, Outstanding Ending \| $ / shares	$ 6.25
Weighted Average Life (years), Outstanding Ending	4 years 5 months 19 days

Subsequent Events (Details) - Forecast [Member]	Sep. 30, 2023 USD ($)
Subsequent Events (Details) [Line Items]
Aggregate value	$ 1,000,000
Class B Common Stock [Member]
Subsequent Events (Details) [Line Items]
Aggregate value	$ 1,000,000

Summary of Significant Accounting Policies (Details) - USD ($)	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Cash balances	$ 250,000
Amount excess	4,800,000
Total contract liabilities	$ 24,874	$ 4,648